Multiple Sclerosis Market Expansion Driven by Disease-Modifying Therapies
The growing prevalence of neurological disorders and continuous advancements in disease-modifying therapies are reshaping the landscape of multiple sclerosis treatment worldwide. Multiple sclerosis (MS) is a chronic autoimmune disease that attacks the central nervous system, causing inflammation, nerve damage, and progressive disability. As healthcare providers increasingly adopt innovative...
0 Comments 0 Shares 9 Views 0 Reviews